Status
Retatrutide approval status checker
As checked on May 3, 2026, retatrutide is investigational and is not FDA approved for public sale or prescription.
Current status
FDA approvalNo FDA-approved public retatrutide product
Retatrutide is investigational and not approved for public sale or prescription.
Availability
Official access contextLilly clinical trials only
Lilly says retatrutide is legally available only to clinical trial participants.
Next check
- Read official FDA and Lilly sources before relying on marketplace claims.
- Use the trial finder for ClinicalTrials.gov records.
- Use approved alternatives for clinician-supervised options.
Medical disclaimer
This tool is for informational purposes only and does not constitute medical advice. I am not a medical professional. Always consult a qualified healthcare provider before starting, stopping, or changing any weight loss treatment. Retatrutide is investigational and is not FDA approved.